Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors:a randomised controlled trial

Transcend Investigators

    Research output: Contribution to journalArticleScientificpeer-review

    872 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1174-1181
    JournalLancet
    Volume372
    Issue number9644
    Publication statusPublished - 2008
    Publication typeA1 Journal article-refereed

    Cite this